The US Food and Drug Administration has declined to respond to a Citizen Petition by North American Reishi Ltd (“Nammex”) on the labeling and sale of food and supplements containing fungal ingredients, citing “competing agency priorities”.
A Nammex-commissioned survey of 10,000 people in the US confirms the population can easily identify a mushroom. The task may seem simple, but the act supports a greater argument by Nammex, the supplier of functional mushroom extracts, that mycelium-containing products are not mushrooms.